Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials

American Journal of Cardiology

Volumn 95, Issue 7, 2005, Pages 896-898

  Dulin, Brian R ^a   Haas, Steven J ^b   Abraham, William T ^b   Krum, Henry ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; METOPROLOL; NEBIVOLOL;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART FAILURE; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SYSTOLE;

EID: 15244356578     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.11.052     Document Type: Article

References (12)

1. The Beta-Blocker Evaluation of Survival Trial Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
2. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman U.S. Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
3. The CIBIS-II Investigators and Committees The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
4. M. Packer, A.J. Coats, M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
5. MERIT-HF Study Group Effect of metoprolol CR/XL randomised intervention trial in congestive heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
6. E. Erdmann, P. Lechat, P. Verkenne, H. Wiemann Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure Eur J Heart Fail 3 2001 469 479
7. C.S. Allada, A.M. Keogh, E. Kotlyar, C.S. Hayward, P. Macdonald Carvedilol in elderly heart failure patients J Am Coll Cardiol 39 suppl A 2002 1113 1146
8. S.G. Thompson, S.J. Pocock Can meta-analyses be trusted? Lancet 338 1991 1127 1130
9. J.A. Berlin, N.M. Laird, H.S. Sacks, T.C. Chalmers A comparison of statistical methods for combining events rates from clinical trials Stat Med 8 1989 141 151
10. J.J. Deeks, D.G. Altman, M.J. Bradburn Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis M. Egger G.D. Smith G.D. Altman Systematic Reviews in Health Care: Meta-Analysis in Context 2nd Ed 2001 BMJ Publishing Group London 285 312
11. M.D. Flather, M.E. Farkouh, J.M. Pogue Strengths and limitations of meta-analysis: larger studies may be more reliable Control Clin Trials 18 1997 568 579 ; 661-666
12. Coats AJS. Randomized trial to determine the effect of hebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-225.